Dynamic Technology Lab Private LTD Global Blood Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $375,420 - $490,244	-9,641 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$37.65 - $63.77 $362,983 - $614,806	9,641 New	9,641 $418,000
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $225,760 - $318,742	-4,279 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $208,515 - $350,107	4,279 New	4,279 $270,000
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $393,020 - $703,996	-8,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $390,010 - $498,025	8,600 New	8,600 $417,000
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $307,010 - $454,285	-9,734 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $369,892 - $497,407	9,734 New	9,734 $370,000
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $283,593 - $367,499	-7,328 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $290,188 - $482,915	7,328 New	7,328 $354,000
Q4 2017 Feb 09, 2018	SELL	$29.7 - $45.7 $196,821 - $302,853	-6,627 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$25.1 - $31.05 $166,337 - $205,768	6,627	6,627 $205,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.